| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | 0.565 | 0.692 | 2.4E-13 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DnaJ heat shock protein family (Hsp40) member C21 | 0.606 | 0.731 | 2.1E-07 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
G protein-coupled receptor 183 | 0.700 | 0.462 | 1.7E-02 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Cbl proto-oncogene C | 0.821 | 0.192 | 4.2E-11 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
GRINL1B complex locus 2 (pseudogene) | 1.000 | 0.038 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
RAD21 cohesin complex component | 0.528 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
SH3 domain containing GRB2 like 1, endophilin A2 | 0.686 | 0.346 | 1.2E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
signal recognition particle 54 | 0.612 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
elongation factor like GTPase 1 | 0.638 | 0.577 | 5.1E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.967 | 60 | 0 | 1979 | 2019 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1979 | 2017 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1979 | 2019 | ||||||||
|
modulator of VRAC current 1 | 0.585 | 0.769 | 3.2E-08 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1980 | 2011 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1981 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.400 | strong | 0.958 | 144 | 0 | 1982 | 2020 | ||||||||
|
lamin B receptor | 0.473 | 0.808 | 0.18 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1982 | 1985 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.987 | 78 | 6 | 1984 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.400 | None | 0.985 | 66 | 0 | 1985 | 2019 | ||||||||
|
MOS proto-oncogene, serine/threonine kinase | 0.617 | 0.500 | 0.59 |
|
disease | 0.050 | None | 0.600 | 5 | 0 | 1985 | 1989 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 231 | 34 | 1986 | 2020 | ||||||||
|
ETS proto-oncogene 2, transcription factor | 0.548 | 0.808 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1986 | 2017 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.400 | None | 0.970 | 101 | 0 | 1987 | 2020 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.100 | None | 0.979 | 47 | 0 | 1987 | 2019 |